Company Filing History:
Years Active: 2016
Title: Hilary J McKenna: Innovator in Antibody Research
Introduction
Hilary J McKenna is a prominent inventor based in Tauranga RD3, New Zealand. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that inhibit TSLP activity. His work has implications for various therapeutic applications, showcasing his innovative spirit and dedication to scientific advancement.
Latest Patents
Hilary J McKenna holds a patent for "Antibodies that inhibit TSLP activity." This invention is directed to purified and isolated novel TSLP polypeptides, the nucleic acids encoding such polypeptides, processes for the production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above. He has 1 patent to his name, reflecting his focused research efforts in this specialized area.
Career Highlights
McKenna is associated with Immunex Corporation, where he has been instrumental in advancing research related to TSLP and its therapeutic potential. His work at Immunex Corporation has positioned him as a key player in the biotechnology sector, contributing to the development of innovative solutions for health challenges.
Collaborations
Throughout his career, Hilary J McKenna has collaborated with notable colleagues, including John Ernest Sims and Stewart D Lyman. These collaborations have enriched his research and expanded the impact of his inventions in the scientific community.
Conclusion
Hilary J McKenna's contributions to antibody research exemplify the importance of innovation in biotechnology. His patent on TSLP inhibitors highlights his commitment to advancing medical science and improving therapeutic options.